Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Klinger

Showing results (21-30 of 274) with videos related to

Pageof 28
Sort By:
Drug Design, Development and Therapy|November 19, 2009
Ambrisentan for the treatment of pulmonary arterial hypertensionBrian Casserly, James R Klinger
The American Journal of Medicine|May 1, 1989
Pulmonary hemorrhage associated with bullous pemphigoid of the lungJ R Klinger, W Donat
Expert Opinion on Investigational Drugs|October 26, 2023
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertensionRoger Auth, James R Klinger
Annali Italiani Di Chirurgia|July 1, 1990
[The medical treatment of obesity]P M Vita, R Klinger
Chest|November 1, 1996
The natriuretic peptides. Clinical applications in patients with COPDJ R Klinger, M Cutaia
Drug Design, Development and Therapy|January 8, 2010
Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agentBrian Casserly, James R Klinger
Critical Care Medicine|August 24, 2007
Pulmonary hypertension in the intensive care unit: Critical role of the right ventricleNicholas S Hill, James R Klinger
Therapeutic Advances in Respiratory Disease|August 19, 2011
Combination therapy for the treatment of pulmonary arterial hypertensionAndrew T Levinson, James R Klinger
Der Orthopade|September 23, 2008
[Can failed back surgery be prevented? Psychological risk factors for postoperative pain after back surgery]R Klinger, F Geiger, M Schiltenwolf
Archives of Dermatological Research|January 1, 1990
Topical interferon-alpha in psoriasis increases epidermal calmodulin activityU Wollina, B Knopf, R Klinger
Pageof 28

Showing results (21-30 of 274) with videos related to

Sort By:
Pageof 28
Drug Design, Development and Therapy|November 19, 2009
Ambrisentan for the treatment of pulmonary arterial hypertensionBrian Casserly, James R Klinger
The American Journal of Medicine|May 1, 1989
Pulmonary hemorrhage associated with bullous pemphigoid of the lungJ R Klinger, W Donat
Expert Opinion on Investigational Drugs|October 26, 2023
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertensionRoger Auth, James R Klinger
Annali Italiani Di Chirurgia|July 1, 1990
[The medical treatment of obesity]P M Vita, R Klinger
Chest|November 1, 1996
The natriuretic peptides. Clinical applications in patients with COPDJ R Klinger, M Cutaia
Drug Design, Development and Therapy|January 8, 2010
Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agentBrian Casserly, James R Klinger
Critical Care Medicine|August 24, 2007
Pulmonary hypertension in the intensive care unit: Critical role of the right ventricleNicholas S Hill, James R Klinger
Therapeutic Advances in Respiratory Disease|August 19, 2011
Combination therapy for the treatment of pulmonary arterial hypertensionAndrew T Levinson, James R Klinger
Der Orthopade|September 23, 2008
[Can failed back surgery be prevented? Psychological risk factors for postoperative pain after back surgery]R Klinger, F Geiger, M Schiltenwolf
Archives of Dermatological Research|January 1, 1990
Topical interferon-alpha in psoriasis increases epidermal calmodulin activityU Wollina, B Knopf, R Klinger
Pageof 28